Difinity Solutions specializes in the development, commercialization and implementation of medical devices in emergency medication delivery systems. By leveraging innovation and direct clinical knowledge, the company is advancing disruptive technologies in medical care.
The flagship device currently under development is NeedSwitch, the world’s first interchangeable and modular autoinjector for emergency and lifesaving medication delivery. Its first target drug will be naloxone to help combat the opioid crisis with plans to expand as a platform technology for other lifesaving medications like epinephrine, TXA, atropine and many more.
With investment from UCeed, the company is focused on further product development in order to fine-tune the NeedSwitch device and complete benchtop testing as it works towards regulatory approval and market entry.
Visit Difinity Solutions’ website for more information.
Difinity Solutions has received investment from UCeed, a venture philanthropy fund accelerating UCalgary and community-based startup companies to advance problem-solving research, create jobs and fuel the economy. A key program in the UCalgary innovation ecosystem, UCeed bridges the gap between innovation, demonstration and commercialization, and is managed by UCalgary’s knowledge-transfer and business incubator, Innovate Calgary.
UCeed Health Fund is supported by the generosity of the River Fund at the Calgary Foundation and its mission to build a healthy and vibrant community where everyone belongs.